Stockreport

CohBar Presents Preclinical Data on CB4209/CB4211 Program for NASH at the AASLD Liver Meeting® 2017

CohBar, Inc.  (CWBR) 
NASDAQ:AMEX Investor Relations: ir.cohbar.com
PDF MENLO PARK, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on developing mitochondria ba [Read more]